Pheon Therapeutics
PrivateLast Round
Series B
May 21, 2024
Total Funding Raised
$188M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pheon Therapeutics is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for a wide range of hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pheon Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pheon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 21, 2024 | ||||
| Series A | Mar 1, 2022 |
Pheon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abio-X | Series B |
| Forbion Capital Partners | Series B, Series A |
| TCG Crossover | Series B |
| Research Corporation Technologies | Series B, Series A |
| Forbion | Series B, Series A |
| Perceptive Advisors | Series B |
| RCT | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Developing new cdcp1-targeting antibody-drug conjugates (ADCs).
- May 21, 2024
$120M round led by TCG Crossover
Pheon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pheon Therapeutics's valuation, stock price, and market status.